𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisplatin and 5-fluorouracil in refractory breast cancer patients: A phase II study

✍ Scribed by Domenico Amoroso; Paolo Pronzato; Gianfilippo Bertelli; Pietro Gallotti; Gisella Pastorino; Maria Pia Cusimano; Marco Merlano; Pier Franco Conte; Riccardo Rosso

Publisher
Springer US
Year
1988
Tongue
English
Weight
233 KB
Volume
11
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of combined 5-fluoroura
A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer
✍ Willy Mattsson; Finn Von Eyben; Lennart Hallsten; GΓΆran Bjelkengren πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 2 views

In a Phase I1 study, 50 patients with advanced breast cancer were treated with a combination of 5fluorouracil(lOO0 mg/m2 on days 1 and 2) and mitomycin C (6 mg/m2 on day 2) (FuMi regimen). The courses were repeated every third to sixth week. Although 35 patients had previously received combination c

5-fluorouracil rechallenge by protracted
5-fluorouracil rechallenge by protracted infusion in refractory breast cancer
✍ Khaled Jabboury; Frankie Ann Holmes; Gabriel Hortobagyi πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 489 KB πŸ‘ 1 views

The authors assessed the value of protracted low-dose 5-fluorouracil (5-FU) infusion (250 mg/m\*/day) in refractory breast cancer. Thirty-six patients with prior 5-FU exposure who were not eligible for other investigational therapeutic measures mainly due to extensive prior chemotherapy (median, fou